Prosecution Insights
Last updated: August 06, 2026
Application No. 18/078,016

APROTIC CATALYSTS FOR THE HYDROLYSIS / CONDENSATION OF ORGANOALKOXYSILANES

Non-Final OA §103
Filed
Dec 08, 2022
Priority
Dec 13, 2021 — provisional 63/288,986
Examiner
XU, JIANGTIAN
Art Unit
1762
Tech Center
1700 — Chemical & Materials Engineering
Assignee
Novinium LLC
OA Round
4 (Non-Final)
65%
Grant Probability
Favorable
4-5
OA Rounds
0m
Est. Remaining
99%
With Interview

Examiner Intelligence

Grants 65% — above average
65%
Career Allowance Rate
222 granted / 340 resolved
At TC average
Strong +34% interview lift
Without
With
+34.5%
Interview Lift
resolved cases with interview
Typical timeline
3y 3m
Avg Prosecution
69 currently pending
Career history
402
Total Applications
across all art units

Statute-Specific Performance

§101
1.0%
-39.0% vs TC avg
§103
56.4%
+16.4% vs TC avg
§102
14.3%
-25.7% vs TC avg
§112
24.2%
-15.8% vs TC avg
Black line = Tech Center average estimate • Based on career data from 340 resolved cases

Office Action

§103
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Election/Restrictions Applicant’s election without traverse of Group I (claims 1-16) in the reply filed on 10/7/2025 is acknowledged. During a telephone conversation with Attorney Barry Davison on 10/20/2025 a provisional election was made without traverse to prosecute the invention of Species A (claim 7). Affirmation of this election was made by applicant in the response of 3/9/2026. Species B-F (claims 8-12) are withdrawn from further consideration by the examiner, 37 CFR 1.142(b), as being drawn to non-elected species. Claim Status The claims filed on 6/10/2026 has been entered. No claim(s) is/are currently amended. Claim(s) 6 and 17-29 has/have been cancelled. Claims 1-5 and 7-16 are pending with claim(s) 8-12 withdrawn from consideration. Claim(s) 1-5, 7 and 13-16 is/are under examination in this office action. Response to Arguments Applicant's argument, filed on 3/9/2026, with respect to 103 rejection has been fully considered but is moot in view of the new grounds of rejection presented below. Claim Rejections - 35 USC § 103 In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. The text of those sections of Title 35, U.S. Code not included in this action can be found in a prior Office action. The factual inquiries for establishing a background for determining obviousness under 35 U.S.C. 103 are summarized as follows: 1. Determining the scope and contents of the prior art. 2. Ascertaining the differences between the prior art and the claims at issue. 3. Resolving the level of ordinary skill in the pertinent art. 4. Considering objective evidence present in the application indicating obviousness or nonobviousness. This application currently names joint inventors. In considering patentability of the claims the examiner presumes that the subject matter of the various claims was commonly owned as of the effective filing date of the claimed invention(s) absent any evidence to the contrary. Applicant is advised of the obligation under 37 CFR 1.56 to point out the inventor and effective filing dates of each claim that was not commonly owned as of the effective filing date of the later invention in order for the examiner to consider the applicability of 35 U.S.C. 102(b)(2)(C) for any potential 35 U.S.C. 102(a)(2) prior art against the later invention. Claim(s) 1-5 and 13-16 is/are rejected under 35 U.S.C. 103 as being unpatentable over Bertini et al (US 8101034 B2) in view of Chen et al (CN 103804687A, machine translation is referenced herein). Regarding claims 1-5 and 13, Bertini teaches a method for imparting excellent long-term dielectric performance to an in-service electrical cable section having a stranded conductor surrounded by a conductor shield encased in a polymeric insulation and having an interstitial void volume in the region of the conductor, the method comprising injecting a dielectric enhancement fluid composition into the interstitial void volume [abstract], wherein the composition comprises a Class 1 component of a water-reactive organosilane monomer having at least two water-reactive groups (i.e., the organosilane can undergo hydrolysis and subsequent condensation) [col.2 lines 15-19, col.24 lines 53-57], including tolylethylmethyldimethoxysilane and 2-cyanobutylmethyldimethoxysilane [col.25 lines 49-53]. The examiner submits that the tolylethylmethyldimethoxysilane and 2-cyanobutylmethyldimethoxysilane reads on the claimed a, at least one organoalkoxysilane, as specified in claims 1 and 13. Bertini teaches that the composition further comprises a condensation catalyst known to promote the hydrolysis and condensation of organoalkoxysilanes [col.25 lines 54-58], but does not teach that the catalyst is the ones specified in the instant claims 1-5 and 7. Pertinent to the same problem, Chen teaches catalysts for silicon hydroxyl condensation reaction including phosphorus pentoxide [0038], which reads on the claimed b, one or more aprotic hydrolysis/condensation catalysts for said organoalkoxysilane(s), as specified in claims 1. It would have been obvious to one of ordinary skill in the art at the time of filing to select phosphorus pentoxide as the condensation catalyst in Bertini’s composition, as it is expressly disclosed as being useful in this capacity. It has been established that selection of a known material based on its suitability for its intended use is prima facie obvious (Sinclair & Carroll Co. v. Interchemical Corp., 325 U.S. 327, 65 USPQ 297 (1945)). See MPEP 2144.07. Formulae (i), (ii), (iv), (v), (vi) and claims 2-5 do not need to be addressed since phosphorus pentoxide meets the claimed b. Regarding claim 14, the recited “corrosion of the conductor during treatment with the dielectric enhancement fluid is reduced or eliminated by the use of the one or more aprotic hydrolysis/condensation catalysts relative to use of protic strong acid catalysts” is a property of the product. “Products of identical chemical composition cannot have mutually exclusive properties." A chemical composition and its properties are inseparable. Therefore, if the prior art teaches the identical chemical structure, the properties applicant discloses and/or claims are necessarily present. “When the PTO shows a sound basis for believing that the products of the applicant and the prior art are the same, the applicant has the burden of showing that they are not.” In re Spada, 911 F.2d 705, 709, 15 USPQ2d 1655, 1658 (Fed. Cir. 1990)). See MPEP 2112.01. Since the prior art teaches the same product as the current invention, the recited property is expected to be present. Nonetheless, Bertini teaches that the combination of the organoalkoxysilane components and the condensation catalyst does not corrode copper or aluminum conductors [col.25 lines 56-60]. Regarding claim 15, Bertini teaches that the conductor comprises aluminum [col.14 lines 48-49]. The recited “wherein corrosion of the aluminum is reduced or eliminated” is a property of the product. “Products of identical chemical composition cannot have mutually exclusive properties." A chemical composition and its properties are inseparable. Therefore, if the prior art teaches the identical chemical structure, the properties applicant discloses and/or claims are necessarily present. “When the PTO shows a sound basis for believing that the products of the applicant and the prior art are the same, the applicant has the burden of showing that they are not.” In re Spada, 911 F.2d 705, 709, 15 USPQ2d 1655, 1658 (Fed. Cir. 1990)). See MPEP 2112.01. Since the prior art teaches the same product as the current invention, the recited property is expected to be present. Nonetheless, Bertini teaches that the combination of the organoalkoxysilane components and the condensation catalyst does not corrode copper or aluminum conductors [col.25 lines 56-60]. Regarding claim 16, the recited PE retention is a property of the product. “Products of identical chemical composition cannot have mutually exclusive properties." A chemical composition and its properties are inseparable. Therefore, if the prior art teaches the identical chemical structure, the properties applicant discloses and/or claims are necessarily present. “When the PTO shows a sound basis for believing that the products of the applicant and the prior art are the same, the applicant has the burden of showing that they are not.” In re Spada, 911 F.2d 705, 709, 15 USPQ2d 1655, 1658 (Fed. Cir. 1990)). See MPEP 2112.01. Since the prior art teaches the same product as the current invention, the recited property is expected to be present. Allowable Subject Matter Claim 7 is objected to as being dependent upon a rejected base claim, but would be allowable if rewritten in independent form including all of the limitations of the base claim and any intervening claims. The following is a statement of reasons for the indication of allowable subject matter: Dependent claim 7 is directed to a method for enhancing the dielectric properties of an electrical cable having a central stranded conductor encased in a polymeric insulation jacket and having an interstitial void volume in the region of the conductor, the method comprising introducing a dielectric enhancement fluid composition into the interstitial void volume, wherein the composition comprises: a. at least one organoalkoxysilane; and b. one or more aprotic hydrolysis/condensation catalysts for said organoalkoxysilane(s), wherein the one or more aprotic hydrolysis/condensation catalyst comprises at least one selected from TIPS triflate (triisopropyl silyltrifluoromethanesulfonate), and DTBS ditriflate (Di-tert-butylsilylbis(trifluoromethanesulfonate). There is no prior art that teaches or makes obvious the aforementioned limitations as claimed. The closest prior art is the disclosure of Bertini et al (US 8101034 B2) in view of Chen et al (CN 103804687A, machine translation is referenced herein). The prior art teaches the claimed method as stated in the 103 rejection. However, the prior art does not teach or suggest that the one or more aprotic hydrolysis/condensation catalyst comprises at least one selected from TIPS triflate (triisopropyl silyltrifluoromethanesulfonate), and DTBS ditriflate (Di-tert-butylsilylbis(trifluoromethanesulfonate). Conclusion Applicant's amendment necessitated the new ground(s) of rejection presented in this Office action. Accordingly, THIS ACTION IS MADE FINAL. See MPEP § 706.07(a). Applicant is reminded of the extension of time policy as set forth in 37 CFR 1.136(a). A shortened statutory period for reply to this final action is set to expire THREE MONTHS from the mailing date of this action. In the event a first reply is filed within TWO MONTHS of the mailing date of this final action and the advisory action is not mailed until after the end of the THREE-MONTH shortened statutory period, then the shortened statutory period will expire on the date the advisory action is mailed, and any extension fee pursuant to 37 CFR 1.136(a) will be calculated from the mailing date of the advisory action. In no event, however, will the statutory period for reply expire later than SIX MONTHS from the date of this final action. Any inquiry concerning this communication or earlier communications from the examiner should be directed to JIANGTIAN XU whose telephone number is (571)270-1621. The examiner can normally be reached Monday-Thursday. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Robert Jones can be reached on (571) 270-7733. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /JIANGTIAN XU/Primary Examiner, Art Unit 1762
Read full office action

Prosecution Timeline

Show 3 earlier events
Mar 09, 2026
Response Filed
Apr 13, 2026
Final Rejection mailed — §103
Jun 10, 2026
Response after Non-Final Action
Jun 18, 2026
Final Rejection mailed — §103
Jun 25, 2026
Response after Non-Final Action
Jul 01, 2026
Request for Continued Examination
Jul 02, 2026
Response after Non-Final Action
Aug 05, 2026
Non-Final Rejection mailed — §103 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12692393
Zwitterionic Polysiloxane for Biomedical Devices
2y 2m to grant Granted Jul 28, 2026
Patent 12686790
POLYMER COMPOSITIONS FOR FORMING AN ENAMEL COATING ON A WIRE
4y 8m to grant Granted Jul 21, 2026
Patent 12662571
Polycarbonate Compositions Containing Polyethercarbonate Polyols
3y 8m to grant Granted Jun 23, 2026
Patent 12655283
AQUEOUS DISPERSIONS CONTAINING CATIONIC POLYVINYL ALCOHOL MODIFIED POLYMER PARTICLES AND AQUEOUS ELECTROCOATING MATERIALS CONTAINING SAID DISPERSIONS
2y 9m to grant Granted Jun 16, 2026
Patent 12649816
THERMOPLASTIC POLYURETHANES DERIVED FROM LIGNIN MONOMERS
3y 8m to grant Granted Jun 09, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

4-5
Expected OA Rounds
65%
Grant Probability
99%
With Interview (+34.5%)
3y 3m (~0m remaining)
Median Time to Grant
High
PTA Risk
Based on 340 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month